On CNBC's “Mad Money Lightning Round,” Jim Cramer said IonQ, Inc. (NYSE:IONQ) is “so high,” and it's also losing so much money.” He added that it's “too speculative” for him.
As per the recent news, IonQ, on May 23, formed a strategic partnership with the Korea Institute of Science and Technology Information, or KISTI, to advance South Korea's quantum technology goals.
Oklo Inc. (NYSE:OKLO) is “literally five years behind GE Vernova (NYSE:GEV),” Cramer said. “I don't have the time for that when I can just go buy GE Vernova.”
As per the recent news, Oklo, on May 27, signed an MOU with Korea Hydro & Nuclear Power to collaborate on the development and deployment of its nuclear technology.
Cramer said he prefers Phillips (NYSE:PSX) over Valero Energy (NYSE:VLO). “I think Valero's already had too much of a run,” he added.
On the earnings front, Valero Energy, on April 24, reported a first-quarter sales of $30.26 billion, beating the analyst consensus estimate of $28.68 billion.
Verona Pharma plc (NASDAQ:VRNA) is a “rocket ship. Again, very, very speculative because it loses a lot of money. Does have a couple things in the pipe that people like, but also has a huge amount of insider selling, frankly,” Cramer said.
Verona Pharma, on April 29, reported mixed results for the first quarter.
“What a horse,” Cramer said when asked about Centrus Energy Corp. (NYSE:LEU). “I suggest that you calm down and you buy GE Vernova (NYSE:GEV).”
On the earnings front, Centrus Energy, on May 7, reported better-than-expected first-quarter revenue results.
Price Action:
- Valero Energy shares gained 1.7% to settle at $130.71 on Tuesday.
- IONQ shares jumped 5.1% to close at $48.04 during the session.
- Verona Pharma shares gained 0.7% to settle at $75.61.
- Centrus Energy shares gained 12.9% to close at $127.86 on Tuesday.
- Oklo shares jumped 10.3% to settle at $53.90.
Read Next:
Photo via Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
